Branded Generics Market Scope And Analysis

  • Report Code : TIPRE00005554
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Branded Generics Market Scope, Size, and Share by 2031

Buy Now

Branded Generics Market Report Branded Generics Market Size and Share Branded Generics Market Scope and Analysis

Branded Generics Market Report Scope

Report Attribute Details
Market size in 2023 US$ 258.85 Billion
Market Size by 2031 US$ 570.40 Billion
Global CAGR (2023 - 2031) 10.38%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Therapeutic Application
  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases
  • Dermatology Diseases
  • Analgesics & Anti-Inflammatory
By Drug Class
  • Alkylating Agents
  • Antimetabolites
  • Hormones
  • Antihypertensive
  • Lipid-Lowering Drugs
  • Antidepressants
  • Antipsychotics
  • Antiepileptic
By Formulation Type
  • Oral
  • Parenteral
  • Topical
By Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Hetero
  • Aspen Holdings
  • Sandoz International GMBH
  • Par Pharmaceuticals INC
  • Dr Reddy s Laboratories
  • AstraZeneca PLC
  • Sanofi
  • Lupin
  • Bausch Health Companies Inc
  • GlaxoSmithKline plc